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Abstract
Trypanosoma vivax is the main species involved in trypanosomosis, but very little is known about the immunobiology of the
infective process caused by this parasite. Recently we undertook to further characterize the main parasitological,
haematological and pathological characteristics of mouse models of T. vivax infection and noted severe anemia and
thrombocytopenia coincident with rising parasitemia. To gain more insight into the organism’s immunobiology, we studied
lymphocyte populations in central (bone marrow) and peripherical (spleen and blood) tissues following mouse infection
with T. vivax and showed that the immune system apparatus is affected both quantitatively and qualitatively. More
precisely, after an initial increase that primarily involves CD4
+ T cells and macrophages, the number of splenic B cells
decreases in a step-wise manner. Our results show that while infection triggers the activation and proliferation of
Hematopoietic Stem Cells, Granulocyte-Monocyte, Common Myeloid and Megacaryocyte Erythrocyte progenitors decrease
in number in the course of the infection. An in-depth analysis of B-cell progenitors also indicated that maturation of pro-B
into pre-B precursors seems to be compromised. This interferes with the mature B cell dynamics and renewal in the
periphery. Altogether, our results show that T. vivax induces profound immunological alterations in myeloid and lymphoid
progenitors which may prevent adequate control of T. vivax trypanosomosis.
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Introduction
African trypanosomes are extracellular parasites that cause
sleeping sickness in humans and Nagana in animals. They include
T. brucei species which infect both humans and ruminants, but also
T. congolense and particularly T. vivax which are responsible for the
vast majority of animal trypanosomosis in sub-Saharan Africa,
South America and South Asia [1–3]. Due mainly to technical
constraints such as a lack of reproducible in vitro culture conditions
and relatively poor accessibility to natural hosts, our understand-
ing of the biology and fate of T. vivax in its vertebrate hosts largely
stems from the extrapolation of data obtained from the
experimental murine infection with T. brucei, T. congolense and T.
ewansi, but just a few studies using T. vivax infected mice [4–8].
Recently, in a move to gain further insight into the host - T. vivax
interaction, we further developed reproducible and reliable in vivo
models of T. vivax infection using three different mouse strains and
the IL 1392 West African isolate (see accompanying paper). Briefly, our
studies showed that all the mouse strain infected with bloodstream
forms of T. vivax developed the characteristic anemia and systemic
alterations that include acute necrosis of the liver and spleen which
are the hallmarks of animal trypanosomosis [9–12].
Previous immunobiological studies of trypanosomosis focused
mainlyon the interaction between trypanosome surfacecoat antigens
(Variant Surface Glycoproteins, VSGs) and host cells [13–15]. The
triggering of polyclonal B cell activation by trypanosomes and the
ensuing hypergammaglobulinemia mainly composed of antibodies
(Ab) that do not recognize parasite antigens or VSGs are also typical
of the infection [16–19]. The mechanisms underlying this process are
still largely unknown. Moreover, the involvement of VSGs in
protecting the parasites againsth o s ts p e c i f i ci m m u n o r e s p o n s e s
provided until recently one of the most exquisite models for the
studyofantigenicvariation.Itthereforefollowed,formanyyears,that
our understanding of the interaction between African trypanosomes
and the immune system was limited to this ‘‘parasite-driven’’ view
where the host’s immune response was restricted to the production of
specific Abs against VSGs. Whereas anti-VSG Ab doubtless
contribute to early control of the infection, resistance to late phases
is not only dependent on specific (parasite-directed) immunoglobulins
but also seems to rely on T-independent processes since athymic mice
and also complement-deficient mice infected with T. rhodesiense are
able to mount anti parasitic responses that are sufficient to increase
mouse survival and healing after an infectious challenge [7,20].
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exerted by T. brucei- and T. congolense- specific Abs over the frequency
and duration of parasitemia waves but not the level of circulating
parasites.ThiscontrastswithT.vivaxinfections wherethe efficiencyof
the host’s Ab response and the parasite-induced negative feedback of
Abs raised against the parasite are responsible for regulating both the
level and duration of parasitemia waves, thus determining disease
severity [21].
In an attempt to throw light on the early events induced by T. vivax
in mouse B cell compartments that may contribute to explaining later
disturbances in the peripheral B cell pool, we studied the impact of
parasite infection both on bone marrow and peripheral lymphoid
tissues. Our results using an outbred strain showed that T. vivax mouse
infection readily results in B cell differentiation accompanied by
massive production of polyclonal immunoglobulins that are mostly
nonspecific of parasite antigens. The infection profoundly disorga-
nized the follicular structure of the spleen and similarly to T. brucei
infection [6] appeared to destroy the B cell marginal zone, certainly
contributingto the substantialfallinB cellpopulationnumbersboth in
the spleen and blood. Numbers of both marginal zone and follicular B
cells decreased in the organ in the course of the infection
concomitantly with a rise in plasmocytes. Bone marrow analysis
showed a sustained and significant increase in the long–term, self-
renewal of stem cells on infection. However, it is the fate of B cells, and
more precisely of B-cell precursors, that seems to be particularly
affected, and this impacts on B cell output. The long-lasting
destruction of the spleen marginal zone by T. brucei was previously
shown to constitute a barrier to the development of efficient B cell
memory and thus to a vaccine-induced B cell response [6]. Our results
presented here further indicate that T. vivax infection disturbs the
development of B cells in bone marrow which could be an obstacle to
immunotherapies against trypanosomosis and even impair unrelated
vaccination strategies in trypanosome-exposed populations [18].
Materials and Methods
Mice, parasites and infection
Trypanosoma vivax isolate ILRAD 1392 was kindly provided by R.
Brun (Swiss Tropical Institute, Basel, Switzerland). The pheno-
typic and molecular identification of this isolate has previously
been described (see accompanying paper). Bloodstream forms of
T. vivax were maintained by weekly passages in 7- to 8-week-old
outbred RjOrl:Swiss mice (CD-1, Janvier, France) by intra-
peritoneal (i.p.) injection of 10
3 bloodstream forms. Outbred mice
were chosen as the experimental model since they present
significantly higher survival rates than BALB/c mice and, as
described before, a detailed histopathological study of the organs
committed by the infection showed similar pathognomonic signs of
the disease to those observed in the infected livestock (see
accompanying paper). Furthermore, parasitemia in outbred mice
reached a plateau by day 10 of the infection and this persisted over
time contrasting with the more tolerant C57BL/6 mice that
showed recurrent waves of parasitemia. Thus, in our model, 7- to
10-week-old male outbred CD-1 mice were infected i.p. with 10
2
bloodstream parasites. Parasitemia was determined every 2 to 3
days using a counting chamber and a light microscope as
described (see accompanying paper). The experiments described
here were performed every 3–5 days throughout the infection, but
for clarity and without any loss of important information, only
days 10 and 20 post infection are portrayed and considered in the
present work since they correspond respectively to peak parasit-
emia in outbred mice and to the day that generally precedes death,
respectively. All animal work was conducted in accordance with
relevant national and international guidelines (see here below).
Ethics statement
All mice were housed in our animal care facilities in compliance
with European animal welfare regulations. The Institut Pasteur is
member of the Committee #1 of the Comite ´R e ´gional d9Ethique
pour l9Expe ´rimentation Animale (CREEA), Ile de France. The
Animal housing conditions and protocols used in the present work
were previously approved by the ‘‘Direction des Transports et de
la Protection du Public, Sous-Direction de la Protection Sanitaire
et de l’Environnement, Police Sanitaire des Animaux’’ under the
number #B 75-15-28 accordingly to the Ethics Chart of animal
experimentation which includes appropriate procedures to
minimize pain and animal suffering. PM has permission to
perform experiments on vertebrate animals #75-846 issued by the
Department of Veterinary Services of Paris, DDSV and is
responsible for all the experiments and protocols carried out
personally or under her direction in the framework of laws and
regulations relating to the protection of animals.
Parasite extracts
Bloodstream forms of T. vivax were collected by cardiac
punction then diluted in buffer A (polysome buffer) before being
centrifuged for 5 min at 1000 rpm to separate the parasites from
the red blood cells. The upper phase was collected and the pellet
washed twice. Supernatants were recovered and pooled. Parasites
were counted, pelleted by centrifugation (15 min at 3500 rpm)
then resuspended at a cell density of 1 to 5610
8 cells/ml in buffer
A. NP40 was then added (1.2 %), the cells were dounced 30 times
with a manual douncer and the suspension centrifuged for 4 min
at 14,000 rpm. The soluble fraction (S14) was recovered and
dialysed over night (O.N.) against phosphate buffered saline (PBS).
Serum immunoglobulins
Total immunoglobulins in the sera, and specific Abs against the
parasite, were determined by ELISA, as described elsewhere [22],
using flat-bottomed plates pre-coated with goat anti-mouse
immunoglobulins or 10 mg/ml of T. vivax S14 extract [23]. Total
IgG or IgM concentrations were deduced from standard curves
Author Summary
Trypanosoma vivax is responsible for animal trypanoso-
mosis, or Nagana, in cattle and small ruminants. Under
experimental conditions, the outbred mouse model
infected with a well studied West African T. vivax isolate
reproduces the main characteristics of the infection and
pathology observed in livestock. Anemia and non-specific
(parasite-directed) polyclonal hypergammaglobulinemia
are the most common disorders coincident with the rise
in parasitemia. Our results presented here show that the
decrease in peripheral B cell populations does not seem to
be compensated by newly arriving B cells from the bone
marrow. The infection nevertheless prompts intense
production of stem cells that mature into myeloid and
lymphoid precursors. In spite of this, B cell numbers are
specifically reduced in the periphery as the infection
progresses. Thus, negative feedback seems to be set in
motion by the infection in the bone marrow, more
precisely affecting the maturation of B precursors and
consequently the output of mature B cells. The origin of
these phenomena is unclear but this doubtless creates a
homeostatic imbalance that contributes to the inefficient
immune response against T. vivax infection.
Immunobiology of Trypanosoma vivax Infection
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Flow cytometry
Spleen and peripheral blood cell (PBL) suspensions (10
7 cels/
ml) were stained with monoclonal Abs diluted in balanced salt
solution containing 1% fetal calf serum and 0.01% azide. PBL cells
were previously treated with ammonium/chloride/potassium
buffer (ACK), pH 7.2, to lyse the red cells. Cells (10
6 cells) were
preincubated with anti-CD16/CD32 (clone 2.4G2) Abs in order to
block immunoglobulin nonspecific binding through Fc receptors.
Cells were stained with directly-labeled (FITC, PE ou Alexa -
FluorH 647) or biotinylated Abs for 30 minutes on ice. The
following Abs were used: CD3 (clone 145.2C11), CD4 (clone GK
1.5), CD5 (clone 53–7.3), CD8 (clone 53–6.7), B220/CD45R
(clone RA3-6B2), mchain (clone R6-60.2), Mac 1 (clone M1/70),
IgD (clone 11–26), CD19 (clone 1D3), Vb5.1+5.2 (clone MR9-4),
Vb6 (clone 44.22.1), Vb8.1+8.2+8.3 (clone F23.1) and Vb14
(clone 14–2). After washings, biotinylated Abs were further
incubated with fluorescein isothiocyanate-streptavidin or phyco-
erythrin-streptavidin conjugates. Two-color acquisition was car-
ried out with a FACS Scan cytofluorometer (Becton Dickinson) or
with a FACScanto (BD biosciences). Dead cells were excluded
from the analysis by gating out propidium iodide-stained cells.
Splenic and PBL lymphocytes were gated on forward-light scatter/
side-light scatter combined gate, and 20000–100000 events were
acquired. Number of cycling lymphocytes (S+G2 and M) in the
spleen was estimated by measuring individual cell ploidy by dual
parameter FSC/SSC combined FACS analysis of cells stained
with propidium iodide. Bone marrow-derived cells from two
femurs/mouse were recovered in HBSS/2% FCS, counted, rinsed
and resuspended at 1610
8 cells/ml. The following Abs from
PharMingen (coupled with FITC, PE, allophycocyanin (APC), or
PE-Cy7) were used: CD3 (clone 145-2C11), Gr1 (clone RB6-8C5),
TER-119 (Ly76), CD45R/B220 (clone RA3-6B2), CD19 (clone
1D3), CD11c (clone HL3), NK1.1 (PK136), Mac 1 (clone M1/70),
CD117/cKit (2B8), Sca1 (clone E13-161.7), CD34 (RAM34), and
CD16/32 (clone 2.4G2). The lineage mix consisted of CD3, Gr1,
TER-119, B220/CD45R, CD19, CD11c, NK1.1 and Mac 1 Abs
coupled to PE. Staining was performed on 5610
6 cells for 30
minutes at 4uC. The cells were then rinsed in HBSS/FCS 2%,
fixed for 10 minutes in 2% paraformaldehyde, rinsed in HBSS/
2% FCS and resuspended in 400 ml of HBSS/2% FCS. Flow
cytometry acquisition of at least 100000–150000 events was
performed in a FACSCanto. Results were analyzed by FlowJo
software (Tree Star, Inc). Prism software (GraphPad, San Diego,
CA) was used for statistical analyses. Intergroup comparisons were
made by an unpaired t test.
Histology and immunohistochemistry
Spleens were removed from control and infected mice 20 days
post-infection (d.p.i.). Mice were initially anesthetized by an
intraperitoneal injection of 0.1 ml per 10 g mouse body weight of
a solution containing 1 mg/ml xylazine (Rompun 2%, Bayer,
Leverkusen, Germany) and 10 mg/ml ketamine (Imalge `ne 1000,
Merial, Lyon, France) and were then sacrificed by cervical
dislocation. After a complete post-mortem examination, the
spleen, liver, kidneys, lung, heart and specimens of the central
nervous system were removed and immediately fixed in RCL2-
CS100 (38%), a non-toxic, formalin-free fixative (Alphelys, Plaisir,
France). Tissue samples from these organs were embedded in
paraffin and five-micrometer sections were cut and stained with
hematoxylin and eosin (HE). The phenotypic profile of the
inflammatory infiltrates was determined by immunohistochemical
analysis using the following primary Ab, diluted in sterile PBS
(VWR, Strasbourg, France) and incubated O.N. at 4uC: rabbit
polyclonal anti-human CD3 Ab to detect T lymphocytes (Dako,
Glostrup, Denmark), rat monoclonal anti-murine B220/CD45R
mAb (clone RA3-6B2) to detect B lymphocytes (Caltag, Burlin-
game, CA, USA), rat anti-murine F4/80 mAb to detect
macrophages (clone BM8, Caltag), and rat anti-murine Ly-49G2
mAb to detect NK cells (clone 4D11, BD Pharmingen, San Diego,
CA, USA). After removing the paraffin (xylene followed by
ethanol), the slides were treated for 20 min with a blocking
solution containing 2% bovine serum albumin diluted in PBS,
prior to primary Ab incubation. Primary Ab against B220/
CD45R, F4/80 and Ly49G2 were visualized using a Histofine
Simple Stain MAX-PO kit (Histofine Biosciences inc, Cambridge,
UK) and primary Ab against CD3 were visualized using
peroxidase-labeled polymer for rabbit polyclonal Ab (EnVision,
Dako, Carpinteria, CA, USA), according to the manufacturer’s
protocol. Color was developed with 3-Amino-9-EthylCarbazole
(AEC chromogen; BD Pharmingen). The sections were then
counterstained with Meyer’s hematoxylin, and cover-slipped for
microscopic examination. Red areas were considered to be
positive, according to manufacturer’s indications.
Statistical analyses
All the experiments were performed three or four times using at
least 4–5 mice per time point and per experimental group. Mice
were analyzed individually and the differences between the groups
used in this study were tested for statistical significance using
Student’s t test whenever appropriate (Prism software, GraphPad,
San Diego, CA). The data are expressed individually or as
arithmetic means +/2 the standard deviation (SD) of the means.
Results
T. vivax infection induces major modifications in the
lymphocyte populations
Classic features of T. vivax trypanosomosis such as severe acute
anemia and the remodeled secondary organs were observed in our
recently developed experimental murine models of T. vivax
infection (see accompanying paper). In the present study, whereas
lymphocytes and white blood cells decreased significantly in the
first 10 days of infection (Figure 1A, left panel), monocytes and
granulocytes numbers were not significantly altered by the
infection (Figure 1B, right panel). In the same manner as with
other trypanosome infections in mice and cattle, T. vivax triggers
marked lymphocyte blastogenesis that swells cell numbers in
secondary lymphoid organs. In fact, as can be seen in Figure 1B,
the number of lymphocytes increased throughout the infection (left
panel), reflecting the stimulation of the immunological apparatus.
We noted that the spleen enlargement observed was not due only
to an increase in cell numbers (1.5 fold) but also to the elevated
number of cycling cells (Figure 1B, right panel) in the organ. Also,
as compared to spleens from uninfected mice, those from infected
individuals included a large number of dead cells (2–3 fold the
number of live cells) that were appropriately excluded from the
present analyses. As a result, despite considerable individual
differences in cell numbers expressed by the mice used in those
studies, spleen enlargement is evident as early as 10 d.p.i. and is
massive at 20 d.p.i., constituting splenomegaly (Figure 1C).
T. vivax infection is associated with severe B lymphocyte
depletion in the spleen
To investigate whether the increase in cell numbers described
above involves all lymphocyte populations or is restricted to
Immunobiology of Trypanosoma vivax Infection
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during the infection and cell suspensions prepared for character-









+ B1 populations were analyzed
(Table 1). Only days 10 d.p.i. and 20 d.p.i., which correspond
respectively to peak of parasitemia in outbred mice and to the day
that generally precedes death were shown as compared to normal
age-matched uninfected controls (see Material and Methods). Firstly,
while the total number of spleen cells increased up to 1.5 fold, the
total number of CD3
+CD5
+ lymphocytes increased 1.8–2 fold at
10 d.p.i.. More precisely, while the CD4/CD8 ratio appeared to
be unaffected in the first 10 days of infection (2.4:1), a fall in CD8
+
cells and an expansion of the CD3
+CD4
+ subset was observed
from 10 d.p.i., significantly increasing the CD4/CD8 ratio (6:1).
Furthermore, and similarly to what has been described elsewhere
for other trypanosoma infections double negative CD4
2CD8
2
(possibly gamma-delta T cells) [24–25] cells increased 5 fold at 10
d.p.i. and accounted for almost 10% of the increase in CD3
+CD5
+
cell numbers (Table 1). When the expression of major TCR-Vb
chains by CD3
+CD5
+ cells was investigated, this failed to show
any preferential growth of a particular T-cell population but rather
reflected the polyclonal nature of the expansion in the T cell
repertoire. At the same time, a progressive significant decrease in
the number of B220
+IgM
+ B cells was pointed out during the
course of infection. Similarly to previous data obtained in cattle
and sheep infected with other trypanosomes [26,27], this
experimental T. vivax infection stimulated the expansion of
CD5
+/loIgM
hi B cells (B1 cells) in the first 10 d.p.i. but a return
Figure 1. T. vivax induces severe splenomegaly as a result of intense blastogenesis. Four to five 8-week-old outbred mice were analyzed
per time point (0, 10 and 20 d.p.i.) and per experiment. Mice were infected i.p. with 10
2 bloodstream forms of T. vivax and compared to control age-
matched uninfected controls. Numbers of peripheral white blood cells (WBC), lymphocytes (A, left panel), monocytes and granulocytes (A, right
panel) were determined individually, as indicated in the methods section, throughout the ensuing infection and expressed as means +/2 SD of the
means. Spleen cells were recovered at different time points and total numbers of lymphocytes were depicted individually given the variable number
of cells obtained from individual outbred mouse used in 4 different groups of experiments (B, left panel); frequencies of cycling cells were also
determined individually in one out of four experiments (B, right panel). Arithmetic means and SD of the means are presented. * p,0,020; ** p,0,007;
*** p,0,0002 when compared with samples from day 0. Macroscopic examination of spleens harvested from three uninfected (normal) and three
infected (20 d.p.i.) outbred mice showing the marked splenomegaly; scale bars=1 cm (C).
doi:10.1371/journal.pntd.0000793.g001
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increases observed in the CD3
+CD4
+ cell count, this commonly
substantiates the B/T cell ratio inversion observed as early as 10
d.p.i.. The frequency of B220
+CD19
+ cells in the spleen was
determined during the infection using additional experimental
groups of mice and corroborated the consistent progressive fall in
the frequencies of splenic B cells (see Figure 2A for one exemple).
However, since lymphocyte cell numbers in the spleen increased
throughout infection (,1.5 fold) total counts of B cells were not
systematically and significantly decreased if evaluated by the
corresponding relative numbers of B220
+CD19
+ (Figure 2B). This
seems to be the consequence of both the individual mouse
differences in CD19 cell frequencies and the variability of total
spleen cell numbers disclosed by the mice in different experimental
groups. Nonetheless, close examination within CD19
+ gated
population revealed dynamic and reliable alterations of B cell
subpopulations in the spleen, as can be evalluated by the separate
representation of mouse data (see Figure S1 for the gating strategy).
Therefore, newly arrived immature B (NAI B) cells increase in the
organ (Figure 2C). In contrast, a gradual and significant decrease
in marginal zone B (MZB) cells and to a lesser extent in follicular B
cell counts is observed during the infection (Figures 2D and 2E), as
similarly described for T. brucei infection [6]. As expected, the
number of plasma/memory cells (IgM
2IgD
2) considerably
increased over time and did not return to normal levels even in
the late stages of the infection (Figure 2F), contrasting with data
obtained in T. brucei-infected mice [6].
In order to gain further insight into spleen cell dynamics, we set
about analyzing the functional architecture of the spleen by in situ
immunohistochemistry. As can be seen in Figure 3, B lymphocytes
were found exclusively in the spleen white pulp of control mice,
more specifically in the lymphoid follicles (Figure 3A). By contrast,
the spleens of infected mice (Figure 3B) showed a markedly
disorganized white pulp associated with severely depleted B cells in
the follicles. Major differences in T lymphocyte distribution were
also observed between the control and infected animals (Figures 3C
and 3D), most probably corresponding to the intense tissue
disorder resulting from substantial cellular infiltration, conspicu-
ously noted for macrophages in the red pulp of infected spleens
(Figures 3E and 3F).
T. vivax infection triggers intense hematopoiesis and
bone marrow population dynamics
The effect of T. vivax infection on the number of bone marrow
cell precursors was studied in an attempt to identify potential
hematopoietic abnormalities that could explain the substantial
decrease in the peripheral counts of B cell populations. Mice were
infected and bone marrow cells recovered and analyzed by flow
cytometry 10 and 20 days post infection (see Materials and Methods
and Figure S2 for gating strategies). The frequency of hematopoietic
stem cells (HSC) and early progenitors was then determined within
the gated lineage
2/lo (lin
2/lo) bone marrow cell fraction that did
not express (or expressed only low levels of) markers for mature
cells. Thus, Figure 4A shows that while untreated controls
possessed a quiescent number of HSCs, the bone marrow was




infected mice. While the total number of bone marrow cells
obtained from two femurs did not increase significantly, HSC
numbers increased twice as early as 7 d.p.i. (not shown) and
remained high throughout the infection (up to 5 fold increase by
20 d.p.i.). Most of these HSCs had only a short-term capacity for
reconstitution since more than 80% expressed CD34 reflecting a
marked switch from the G0 state to an active cell cycle (data not




+ gate include a third of cells expressing low levels




Commun Lymphoid Progenitors (CLP), gives rise to all lymphoid
lineages and differentiates from HSC after up-regulation of IL-7R
(not determined here). As a result, the marked increase in HSC/
CLP combined population, reflects the intense hematopoiesis
triggered by the infection. It is important to note the marked
decreases observed in lin
2ckit
+Sca1
2 marrow cell populations
over the first 10 days of the infection that persisted over time
(Figure 4B). The distribution of these cells in relation to the
expression of CD16/32 and CD34 cell markers (Figure 4B, right
panels), showed that the frequencies of Granulocyte-Monocyte
Precursors (GMP, CD16/32
+CD34
hi) and Common Myeloid
Progenitors (CMP, CD16/32
+CD34
lo) were significantly altered
by the infection as compared to uninfected controls. It is
interesting to note that although Megakaryocyte Erythrocyte
Precursor numbers (MEP, CD16/32
2CD34
2) decreased upon
infection (see Figure 1B, right panel), this decrease only became
statistically significant on day 21 of the infection, just before death
(not shown) corroborating the previously observed thrombocyto-
penia (see accompanying paper and [10,28]). Interestingly, the




phenotype [29] increased substantially in number during the
infection (Figure 4C) and peaked on day 20.
Peripheral B lymphocyte exhaustion is associated with a
defect in B cell development
We next analyzed bone marrow cell populations committed to
the B cell lineages. As can be seen in Figure 5A CD19
+ cell counts
decreased significantly throughout the course of infection.
Similarly, the number of Pre B + Pro B (CD19
+IgM
2) cell
progenitors in the CD19
+ gated population decreased more than
10 fold during the course of infection (Figure 5B; see Figure S3 for
gating strategy). It is noteworthy that marked individual differences,
but statistically significant, were observed for CD19
+IgM
2 at late
stages of the infection (i.e. day 20), when generally only 40% of the
infected individuals are still alive (see accompanying paper). Some
fluctuations were observed in the number of immature/mature B
cells (CD19
+IgM
+) from day 7 of infection (not shown). This cell
population then significantly decreased 10 d.p.i. at the peak of
Table 1. Changes in spleen cell populations.
Cell Type (x 10
6) Uninfected 10 d.p.i. 20 d.p.i.
Total Spleen cells 145.0639.9 188.0655.7 * 215.0657.1 ***
CD3
+ CD5
+ 62.063.1 125.0653.8 * 138.0637.0 ***
CD3
+ CD4
+ 54.269.9 70.7640.5 122.0617.1 *
CD3
+ CD8




2 2.2961.3 10.167.4 13.0612.3
CD3
+ Vb5
+ 3.560.02 13.967.0 11.167.5
CD3
+ Vb6
+ 26.163.4 26.3611.2 29.3610.8
CD3
+ Vb8
+ 35.2612.4 57.1641.4 41.167.21
CD3
+ Vb14
+ 4.762.3 2.762.0 8.962.4
B220
+ IgM
+ 74.3612.3 60.8636.5 42.8613.3 *
CD5
loIgM
+ (B1) 5.762.0 17.169.5 7.563.5
Arithmetic means 6 SD of the means of two independent experiments
performed with at least 3–5 mice per group analyzed individually. * p,0.0360,
*** p,0.0004 when compared with means from day 0.
doi:10.1371/journal.pntd.0000793.t001
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time point (0, 10 and 20 d.p.i.). Mice were infected i.p. with 10
2 bloodstream forms of T. vivax and spleen cells were recovered 10 and 20 days post
infection for comparison with those recovered from age-matched normal uninfected controls. Spleen cells were stained by immunofluorescence with
specific Abs directed against CD45R/B220 (B220) and CD19. Two-color acquisition was carried out on a FACS Scan cytofluorometer and the results
analyzed using FlowJo software. The figure depicts the results of a representative experiment out of three using the similar number of individuals. SD
of the means are presented. * p,0,038; ** p,0,003 when compared with samples from day 0. The dot plots illustrate the FACS distribution of mouse
spleen cells according to the expression of CD19 and B220 at 10 d.p.i and 20 d.p.i., as compared to cells from normal uninfected mice; similar results
were obtained in different mice drawn from the same group and analyzed individually (A). Arithmetic means of total lymphocyte numbers (upper
panel) or individual CD19
+ cell counts (lower panel) are depicted +/2 standard deviation of the means (B). CD19
+ cells were gated and distributed in




B-T1) (C), Marginal Zone B cells (CD19
+IgM
hiIgD
lo, MZB) (D), Follicular B cells (CD19
+IgM
lo/hiIgD




2, Plasma/Mem B) are shown in (F).
doi:10.1371/journal.pntd.0000793.g002
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www.plosntds.org 6 August 2010 | Volume 4 | Issue 8 | e793Figure 3. Loss of splenic B lymphocytes is associated with marked macrophage infiltration. Serial sections of spleens from uninfected
controls (A, C and E) and from mice infected with 10
2 bloodstream forms of T. vivax 20 d. p. i. (B, D and F) were fixed and further stained with B220 (A,
B), anti-CD3 (C, D) or anti-F4/80 (E, F) to detect B lymphocytes, T lymphocytes and macrophages, respectively. The sections are representative of 5
mice analyzed individually per time point. For information, frequencies of gated splenic macrophages using specific Mac-1 antibodies obtained by
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These findings are consistent with the emigration of these
immature/mature B cells to reconstitute the peripheral B cell
pool. However, after 10 days of infection, while more than 70% of




+/hi) were seen to grow in number as the infection
progressed, but their differentiation into pre-B cells appeared to be




2/lo (Figure 5B, right panel). Altogether, these
results suggest that the process of B cell hematopoiesis is disturbed
flow cytometry using an enlarged forward scatter/side scatter combined gate of spleen cell suspensions corresponded to 7.6% and 6,75%
respectively, for days 10 and 20 of infection, as compared to 2,29% obtained from normal uninfected mice.
doi:10.1371/journal.pntd.0000793.g003
Figure 4. T. vivax infection induces increased hematopoiesis but a collapse in granulocyte/monocyte, common myeloid and
megakaryocyte precursors. Mice were infected i.p. with 10
2 bloodstream forms of T. vivax. Pool of bone marrow cells were obtained from both
femurs of three to six 8-week-old outbred mice then analyzed per animal at 10 and 20 d.p.i. by immunofluorescence and compared with bone
marrow cells from normal age-matched uninfected controls. FSC-A/SSC-A and FSC-W/FSC-H combined plots were used to gate total bone marrow
cells and to eliminate doublets and debris (for gating strategy, see Figure S2). Increases in the number of hematopoietic stem cells (HSC) during the
infection (cKit
hiSca1
+) within the ‘‘lineage negative’’ (lin
2) gated population, are depicted in (A). Granulocyte-monocyte Precursors (GMP, CD16/
32
+CD34
hi), Multipotent Common Myeloid Precursors (CMP, CD16/32
+CD34
lo) and Megakaryocytes and Erythroblasts Precursors (MEP, CD16/
32
2CD34
2) (B, right panel), were obtained from gated lin
2cKit
+Sca1




+ cell numbers are shown (C). Results are expressed per individual mouse and are representative of at least 2 different experiments per
time point. Arithmetic means 6 SD of the means are presented. * p,0.01, ** p,0.005, *** p,0.0001 when compared with samples from day 0.
doi:10.1371/journal.pntd.0000793.g004
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The massive hypergammaglobulinemia induced by the
infection is mainly composed of antibodies that do not
recognize parasite antigens
A study made of CD19
+ PBL B cells in relation to their
expression of IgM and IgD detected several sub-populations of
circulating B cells (see Figure S4 for gating strategy). Thus, late in the
infection, the number of cells recently immigrated from the bone
marrow (Transitional B) increases in parallel with the fall in
numbers of B cells in lymphoid organs (Figure 6A). It was also
noted that the number of naı ¨ve B lymphocytes decreased
considerably throughout the study period analyzed, contrasting
with the relative rise of ‘‘switched’’ plasma/memory cells
(IgM
2IgD
2). In order to determine the impact of the decreased
B lymphocyte repertoire on the production of immunoglobulins,
total IgM and IgG serum levels were quantitated during the
infection and their ability to recognize parasite antigens was
determined. Sera obtained from the infected mice were tested
individually for their ability to react with total T. vivax extracts
prepared at the peak of parasitemia (10 d.p.i.) given that outbred
mice showed a parasitemia plateau after 10 d.p.i. that seems
coherent with a parasite population expressing thereafter the same
variable antigen (VAT). While IgM and especially IgG increased
5–10 fold on infection (Figure 6B), Ab production only partially
correlate with a capability to specifically recognize T. vivax
antigens (Fig. 6C). As expected, IgM specific antibody titers
directed against the parasite were regularly maintained throughout
Figure 5. T. vivax infection leads to elevated bone marrow dynamics and alterations in the maturation of B-cell progenitors. Mice
were infected i.p. with 10
2 bloodstream forms of T. vivax. Pools of bone marrow cells were obtained from both femurs of four to eight 8-week-old
outbred mice then analyzed per animal at 10 and 20 d.p.i. by immunofluorescence and compared with bone marrow cells from normal age-matched
uninfected controls. Cells were stained for IgM, CD19 and CD43, and SSC-A/FCS-A combined plots were used to gate lymphocyte populations.
Doublets were eliminated by a FSC-W/FSC-H combined gate (see Figure S3, for gating strategy). CD19
+ cells were gated and total numbers of positive
cells per 2 femurs are depicted in (A); PreB + Pro B (CD19
+IgM
2) and late immature/mature B (CD19
+IgM
+) cell numbers are shown respectively in (B)
and (C); total numbers of Pro-B and Pre-B cells (B, right panel) were deduced from the expression of CD43 by CD19
+IgM
2 Pre B + Pro B gated cells.
Results are expressed per individual mouse and are representative of at least 3 different experiments per time point. Arithmetic means 6 SD of the
means are presented. * p,0.05, ** p,0.001, *** p,0.0001 cell when compared with samples from day 0.
doi:10.1371/journal.pntd.0000793.g005
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produced IgM responses directed to (possibly new) VSGs (1/100
to 1/500 dilution out of 1–5 mg/ml of seric IgM). This
observation contrasted with the high levels of non specific
polyclonal IgG recorded at the same time period (only 1/25 to
1/100 serum dilution out of 10–20 mg IgG/ml reacts with T. vivax
extracts). This high production of IgG Abs correlates with the rise
in peripheral ‘‘switched/memory’’ (IgM
2IgD
2) B cells, possibly
engaged with the production of ‘non-IgM’ classes or isotypes of
immunoglobulins. These data more than substantiating the
polyclonal nature of the B cell response induced by the infection,
indicate that T. vivax induces a B cell response that is for the most
Figure 6. T. vivax infection results in massive production of non-specific IgG. PBL and sera from individual mice were collected at different
time points following infection with 10
2 bloodstream forms of T. vivax. PBL cells obtained from 2 uninfected and 4 infected mice per group were
subjected to FACS analysis and numbers of recently immigrated ‘‘transitional’’ B cells (IgM
hiIgD




germinative center ‘‘switched’’ plasma/memory B cells (CD19
loIgM
2IgD
2) determined per individual mouse (A) within the CD19
+ gated population
(for gating strategy see Figure S4). Total circulating IgM and IgG immunoglobulins (B) and parasite-specific IgM and IgG titers were determined
individually (C). Results in B and C were obtained from at least 12 different mice per time point from different experiments. For information,
experiments performed with C57BL/6 mice showed similar amounts of total IgG (20 mg/ml by day 20) but ten fold higher quantities of total IgM
(10 mg/ml by day 20), but similarly low titers of parasite specific IgG and IgM responses were observed (1/300 an 1/100, respectively). Arithmetic
means 6 SD of the means are presented. * p,0.05, ** p,0.001, *** p,0.0001 when compared with samples from day 0.
doi:10.1371/journal.pntd.0000793.g006
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strategies.
Discussion
The work described herein provides evidence that experimental
Trypanosoma vivax infection induces rapid and marked bone
marrow hematopoiesis, and a significant delay in the maturation
of B-cell progenitors. Maintenance of the peripheral B cell pool
requires the continuous input of newly formed B cells [30].
Although our findings show that mature B cells are recruited into
the periphery to replenish the pool of terminally differentiated Ig-
secreting cells responsible for the massive hypergammaglobulin-
emia triggered by the infection, an imbalance in B cell
development and supply nevertheless persists. Furthermore, early
infection decreases the frequency of downstream B-cell progeni-
tors, consequently reducing the flow of mature B cells into the
periphery. It was previously shown that parasite-derived B cell
directed apoptotic signals cause severe destruction of the available
B cell pool in the spleen [6]. Our present findings show in addition
that the infection also disturbs bone marrow maturation dynamics,
thereby preventing homeostasis. Moreover, a critical drop of
Granulocyte-Monocyte and Common Myeloid follows the infec-
tion. In addition, the significant decrease of Megakaryocyte
Erythrocyte Precursors supports the thrombocytopenia observed
with the onset of parasitemia (accompanying paper).
As expected, the infection triggers rapid and persistent bone
marrow activity leading to the production of high levels of long-
term reconstituting stem cells. HSC activation is accompanied by
significant bone marrow dynamics but not by the appropriate
differentiation of progenitors committed to both myeloid and
lymphoid lineages. Rather, the infection induces the expression of
Sca-1 in a considerable number of ckit
2 hematopoietic progen-
itors, possibly resulting from the release of pro-inflammatory
cytokines, as postulated [29,31]. It is also possible that CpG-DNA
motifs released from the parasite may trigger the production of
IFN type I, lead to the intense activation of B cells and equally
contribute to the expression of Sca-1 by bone marrow cells [32–
34]. These recently described ckit
2Sca-1
+ bone marrow cells [29]
possess the potential to more rapidly generate B and T cells than
CLPs. Therefore, it is possible that a time lag in the maturation of
lymphoid and myeloid precursors is observed as a consequence of
differential ontogenesis. Although speculative, one hypothesis
would consider that parasite-derived mitogenic (or superantigenic)
effect on B cells at the periphery could bring about a
compensatory effect in the bone marrow to reestablish homeosta-
sis. However, our results indicate a deficiency (or developmental
arrest) in B-cell precursors further impacting on the availability of
mature B cells at the periphery and altering the B: T cell ratio in
lymphoid organs.
Mouse infection with T. brucei results in profound spleen
remodeling with a dramatic drop in IgM
+ marginal zone B cells
(MZB) due to specific apoptosis [6]. Our studies provide further
evidence that the mouse infection with T. vivax causes a marked









hi follicular B cells. It would thus
appear that the splenomegaly and the increase in cellularity
observed result from intense, compensatory T-cell blastogenesis
and a significant infiltrative process, mostly composed of
macrophages. These findings are supported by the fact that
GMP bone marrow numbers decrease by the second week of
infection, compatible with the further mobilization of macro-
phage/monocyte cells to committed organs, as confirmed by
histopathological studies. Since no bone marrow atrophy is seen
during T. vivax infection, several different hypotheses may be
advanced to explain the recurring waves of activation/repression
that affect some specific bone marrow-derived progenitors and the
consequent delay in B cell development which impacts on the
release of B cells to the periphery. One hypothesis considers the
possible down regulation of c-kit expression by marrow cells that
are unable to respond to stromal cell factors, thus compromising
the generation of new lineage progenitors [35]. However, this is
unlikely given that lin
2ckit
hi increase in number in the course of
the infection. Instead, a deficiency in IL-7 (or IL-7R) and IL-12,
which greatly commits HSC into lymphopoiesis, or an increase in
IL-15 which interferes more specifically with pre-B cell prolifer-
ation, may impair the development and maturation of bone
marrow-derived progenitors [36–39]. For instance, it was
previously reported that increases in TGFbcause down regulation
of both IL-7 [40] and VCAM-1 gene expression [41] by stromal
cells, interfering with the self-renewal and differentiation of B-cell
precursors. However, only a few studies concerning the differential
regulation of cytokine expression in mice that are more susceptible
or more tolerant to T. brucei and T. congolense infections are
currently available to further substantiate these hypotheses [42–
45]. Interestingly, recent reports have attributed the disappearance
of peripheral blood leukocytes to a parasite released factor that,
through CD45, manipulates the host’s cytokinic and adaptive
responses, inducing lymphotoxicity [7,46].
Major dysfunctions in the development of bone marrow cell
lineages and greatly impacting on the availability of peripheral
lymphoid repertoires have previously been described in other
infection models, especially those using MCMV and LCMV
viruses [47–49]. These abnormalities were shown to be associated
with the inability of B- and T-cell subsets to respond to
homologous and heterologous antigens, characterizing nonspecific
polyclonal lymphocyte responses and the immunosuppression that
invariably follows infectious processes [18]. In agreement with the
results obtained in livestock and in experimental trypanosome
infections, and more specifically with T. vivax-infected cattle
[18,50–52], we show here that the infection in the mouse
experimental model also induces non-specific (but microorgan-
ism-triggered) polyclonal B cell responses. This is worsened by the
presence in the spleen of numerous abnormal plasmocytes (Mott
cells) that are defective in the production of immunoglobulins (see
accompanying paper). The presence of Mott cells in the plasma
and their relationship with the failure of individuals infected with
African trypanosomes to mount efficient B cell responses, has
previously been described [53]. It is possible that MZB cells
emigrating from the spleen red pulp differentiate into short-lived
plasma cells that would mainly produce T-independent, non
parasite-directed, B cells responses. However, the rapid decay of
MZB cells is rather compatible with these cells playing a role in the
capture of new VSG expressed by the parasite during the infection
and their subsequent transport into the splenic follicules for
antigen presentation to follicular B cells. This hypothesis seems
consistent with our present and other previous data obtained with
T. brucei infected mice [6], where similar decreases of follicular B
cells as the infection progresses parallels the increase of IgM-
producing (parasite-specific) plasma cells at the periphery. The
inability of infected individuals to produce long-lasting amounts of
antigen-specific IgG Abs and the levels of antigenic variation
displayed by the parasites impose major difficulties that prevent
immune intervention against trypanosomosis. The experimental
model described here may stimulate further studies on B cell
development and fate following T. vivax infection and contribute to
unraveling pathways of the host-parasite interaction that could
help in the design of new therapies for disease control.
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Figure S1 Gating strategy for the analysis of B cell populations
in the spleen. Spleen cells were stained with CD19, IgM and IgD
antibodies. 105 events were acquired in a FACScanto (BD
biosciences). Lymphocytes were analyzed inside a combined FCS/
SSC gate. CD19
+ cells were gated and distributed in double plots
for IgD and IgM expression. Frequencies of the different B cell
populations were determined by the differences in the expression
of these markers inside the gated population, as follows: Newly
arrived immature B cells (IgMhiIgD-/lo, NAI B); Marginal Zone
B cells (IgMhiIgDlo, MZB); Follicular B cells (IgMlo/hiIgDhi, Fo
B) and Plasma/memory B cells (IgM-/loIgD-, Plasm/Mem B).
The figure shows examples of plots obtained with a normal,
uninfected mouse or 20 d.p.i. mouse inoculated with 102
bloodstream forms of T. vivax.
Found at: doi:10.1371/journal.pntd.0000793.s001 (0.38 MB TIF)
Figure S2 Gating strategy for the analysis of bone marrow cell
lineages and progenitors. Bone marrow (BM) cells obtained from 2
femurs were stained with a combination of antibodies for multi-
parameter flow cytometry (see Materials and Methods). Briefly,
100000–150000 events were acquired in a FACScanto (BD
biosciences). (A) Combined FSC-A/SSC-A and FSC-H/FSC-W
gates were used to gate single BM cells. Cells were then analyzed
for the expression of lineage markers (lin). Hematopoietic stem
cells (HSC) and early progenitors were gated within the lin-/lo
fraction as they do not express, or express low levels of mature cell
markers. (B) Frequencies of Lin-/lo BM cells were further
analyzed for the expression of Sca1 and c-Kit. LSK (lin-/
loSca1+cKit+) fraction contains the HSC and was used to
determine the frequencies of short and long reconstituting cells
by their expression of CD34 (not shown). Identification of
progenitor populations was performed using the lin-/loS-
ca1+cKit+ BM gated cells and their expression of CD16/32 and
CD34, as follows: Granulocyte/macrophage progenitors (CD16/
32hi/CD34hi, GMP); Common myeloid progenitors (CD16/
32lo/CD34hi, CMP) and Magakaryocyte/erythrocyte progenitors
(CD16/32-CD34-, MEP). The figure shows examples of plots
obtained with a normal, uninfected mouse or 20 d.p.i. mouse
inoculated with 102 bloodstream forms of T. vivax.
Found at: doi:10.1371/journal.pntd.0000793.s002 (0.69 MB TIF)
Figure S3 Gating strategy for the analysis of bone marrow cell B
cell precursors. Bone marrow (BM) cells obtained from 2 femurs
were stained with a combination of antibodies for multi-parameter
flow cytometry (see Materials and Methods). Briefly, 100000–
150000 events were acquired in a FACScanto (BD biosciences).
(A) Combined FSC-A/SSC-A and FSC-H/FSC-W gates were
used to restrain the analysis to single BM lymphoid cells. BM cells
were further analyzed on the basis of lineage markers (lin). (B) lin+
fraction was then distributed for the expression of CD19. CD19
+
cells were gated and frequencies of Pre+Pro B cells and late
immature/mature B cell populations were identified on the basis
of IgM expression inside the gated population. The expression of
CD43 by Pre+Pro B gated cells (lin+CD19+IgM-) gave rise to the
determination of Pre-B (CD43
2) and Pro-B (CD43
+) cell
frequencies. The figure shows examples of plots obtained with a
normal, uninfected mouse or 20 d.p.i. mouse inoculated with 102
bloodstream forms of T. vivax.
Found at: doi:10.1371/journal.pntd.0000793.s003 (0.48 MB TIF)
Figure S4 Gating strategy for the analysis of of B cell
populations in blood. PBL cells were stained with CD19, IgM
and IgD antibodies. 20000 events were acquired in a FACScanto
(BD biosciences). Lymphocytes were analyzed inside a combined
FCS/SSC gate. CD19
+ cells were gated and distributed in double
plots for IgD and IgM expression. Frequencies of the different B
cell populations inside the CD19
+ population were determined by
the differences in the expression of these markers, as follows: Naive
B cells (IgMlo/hiIgDhi, Naı ¨ve B); Marginal Zone-type B cells
(IgMhiIgDlo, MZB-type); Transitional B cells (IgMlo/hiIgD-/lo,
Transitional B) and ‘‘Switched’’/memory B cells (IgM-IgD-,
‘‘Switched’’/Mem B). The figure shows examples of plots obtained
with a normal, uninfected mouse or 20 d.p.i. mouse inoculated
with 102 bloodstream forms of T. vivax.
Found at: doi:10.1371/journal.pntd.0000793.s004 (0.37 MB TIF)
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